GSK plc Buys Back Own Shares
Ticker: GLAXF · Form: 6-K · Filed: Jun 11, 2025 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | Jun 11, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-buyback, stock-transaction
TL;DR
GSK is buying back its own stock via Merrill Lynch.
AI Summary
On June 11, 2025, GSK plc announced through its corporate stockbroker, Merrill Lynch International, that it has purchased a number of its own ordinary shares. The filing does not specify the exact number of shares or the total dollar amount of the transaction.
Why It Matters
Share buybacks can signal management's confidence in the company's valuation and potentially increase earnings per share.
Risk Assessment
Risk Level: low — This filing is a routine report of a company repurchasing its own shares, which is a common corporate action.
Key Players & Entities
- GSK plc (company) — The company making the share purchase.
- Merrill Lynch International (company) — The corporate stockbroker acting on behalf of GSK plc.
- June 2025 (date) — The period during which the transaction occurred.
- 31 1/4 pence (dollar_amount) — The nominal value of each ordinary share purchased.
FAQ
What was the specific number of GSK plc ordinary shares purchased?
The filing states that GSK plc purchased 'the following number of the Company's ordinary shares' but does not specify the exact quantity in the provided text.
What was the total dollar amount of the share repurchase program?
The filing announces the purchase of shares but does not disclose the total monetary value of the transaction.
On what date did the share repurchase transaction occur?
The filing is dated June 11, 2025, and pertains to transactions for the month of June 2025, indicating the purchase happened on or around this date.
Who is acting as GSK plc's corporate stockbroker for this transaction?
Merrill Lynch International is acting as GSK plc's corporate stockbroker for this transaction.
What is the nominal value of GSK plc's ordinary shares?
The nominal value of GSK plc's ordinary shares is 31 1/4 pence each.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 11, 2025 regarding GSK plc (GLAXF).